All PlansAdministrativeLow impact

Newsletter Vol. 3, No. 60

Q: Who is affected by this change?

This affects New Jersey Medicaid Family Medicine, Internal Medicine, Pediatrics, Infectious Disease, Pulmonology providers in NJ on All Plans plans.

New Jersey Medicaid·NJ · Family Medicine, Internal Medicine, Pediatrics +2 more·Provider Notice

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

This provider notice informs healthcare facilities about licensed drugs for prophylaxis and treatment of Influenza Type A infections. It details when RIMANTIDINE and AMANTADINE can be used as antiviral agents alongside vaccination for outbreak control, high-risk patient protection, and healthcare worker prophylaxis.

Action Required

Action needed

No immediate billing changes required. This is an informational notice about available antiviral treatments for Influenza A. Providers should be aware that RIMANTIDINE and AMANTADINE are available options for prophylaxis and treatment in specific clinical situations, but no billing process changes are mandated.

Related policy hubs

New Jersey Medicaid policies NJ policy changes Family Medicine Internal Medicine Pediatrics Infectious Disease Pulmonology